RhumbLine Advisers’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $53.3M | Buy |
243,720
+6,923
| +3% | +$1.51M | 0.05% | 331 |
|
2025
Q1 | $53M | Buy |
236,797
+17,711
| +8% | +$3.97M | 0.05% | 318 |
|
2024
Q4 | $71.8M | Buy |
219,086
+32
| +0% | +$10.5K | 0.06% | 247 |
|
2024
Q3 | $65.8M | Buy |
219,054
+1,245
| +0.6% | +$374K | 0.06% | 272 |
|
2024
Q2 | $71.7M | Buy |
217,809
+4,822
| +2% | +$1.59M | 0.07% | 240 |
|
2024
Q1 | $84.3M | Buy |
212,987
+7,074
| +3% | +$2.8M | 0.08% | 219 |
|
2023
Q4 | $72.5M | Sell |
205,913
-3,522
| -2% | -$1.24M | 0.08% | 228 |
|
2023
Q3 | $78.6M | Sell |
209,435
-1,106
| -0.5% | -$415K | 0.09% | 195 |
|
2023
Q2 | $80.5M | Buy |
210,541
+2,305
| +1% | +$882K | 0.09% | 196 |
|
2023
Q1 | $72.1M | Sell |
208,236
-1,690
| -0.8% | -$586K | 0.09% | 211 |
|
2022
Q4 | $49.4M | Buy |
209,926
+7,783
| +4% | +$1.83M | 0.07% | 274 |
|
2022
Q3 | $49.7M | Buy |
202,143
+4,743
| +2% | +$1.17M | 0.07% | 247 |
|
2022
Q2 | $59.7M | Buy |
197,400
+11,202
| +6% | +$3.39M | 0.09% | 207 |
|
2022
Q1 | $76.5M | Buy |
186,198
+2,679
| +1% | +$1.1M | 0.1% | 181 |
|
2021
Q4 | $86.1M | Buy |
183,519
+25,770
| +16% | +$12.1M | 0.11% | 164 |
|
2021
Q3 | $67M | Sell |
157,749
-2,220
| -1% | -$942K | 0.09% | 191 |
|
2021
Q2 | $57.4M | Sell |
159,969
-5,176
| -3% | -$1.86M | 0.08% | 232 |
|
2021
Q1 | $46.5M | Sell |
165,145
-3,192
| -2% | -$899K | 0.06% | 265 |
|
2020
Q4 | $47.7M | Sell |
168,337
-24,758
| -13% | -$7.01M | 0.07% | 253 |
|
2020
Q3 | $53.1M | Sell |
193,095
-27,670
| -13% | -$7.61M | 0.08% | 213 |
|
2020
Q2 | $50.2M | Sell |
220,765
-37,094
| -14% | -$8.43M | 0.08% | 206 |
|
2020
Q1 | $39.3M | Buy |
257,859
+13,005
| +5% | +$1.98M | 0.08% | 217 |
|
2019
Q4 | $36.8M | Sell |
244,854
-1,020
| -0.4% | -$153K | 0.06% | 290 |
|
2019
Q3 | $34.9M | Sell |
245,874
-3,257
| -1% | -$462K | 0.06% | 277 |
|
2019
Q2 | $31.2M | Buy |
249,131
+11,018
| +5% | +$1.38M | 0.06% | 308 |
|
2019
Q1 | $26.2M | Sell |
238,113
-11,039
| -4% | -$1.22M | 0.05% | 340 |
|
2018
Q4 | $24.4M | Buy |
249,152
+63,381
| +34% | +$6.21M | 0.05% | 332 |
|
2018
Q3 | $22.9M | Buy |
185,771
+5,710
| +3% | +$705K | 0.04% | 398 |
|
2018
Q2 | $17.9M | Sell |
180,061
-7,836
| -4% | -$778K | 0.04% | 475 |
|
2018
Q1 | $16.6M | Buy |
187,897
+15,558
| +9% | +$1.37M | 0.03% | 489 |
|
2017
Q4 | $17M | Sell |
172,339
-9,703
| -5% | -$957K | 0.03% | 492 |
|
2017
Q3 | $17.5M | Buy |
182,042
+18,477
| +11% | +$1.78M | 0.04% | 467 |
|
2017
Q2 | $15.5M | Buy |
163,565
+2,888
| +2% | +$273K | 0.04% | 487 |
|
2017
Q1 | $13.1M | Buy |
160,677
+4,362
| +3% | +$356K | 0.03% | 549 |
|
2016
Q4 | $13.3M | Buy |
156,315
+7,020
| +5% | +$595K | 0.03% | 511 |
|
2016
Q3 | $11.1M | Buy |
149,295
+8,974
| +6% | +$669K | 0.03% | 531 |
|
2016
Q2 | $10.6M | Sell |
140,321
-9,884
| -7% | -$750K | 0.03% | 519 |
|
2016
Q1 | $10.4M | Sell |
150,205
-39,570
| -21% | -$2.74M | 0.03% | 521 |
|
2015
Q4 | $11.4M | Buy |
189,775
+3,100
| +2% | +$187K | 0.04% | 466 |
|
2015
Q3 | $10.1M | Buy |
186,675
+33,325
| +22% | +$1.8M | 0.03% | 502 |
|
2015
Q2 | $8.91M | Sell |
153,350
-6,020
| -4% | -$350K | 0.03% | 564 |
|
2015
Q1 | $9.6M | Buy |
159,370
+5,860
| +4% | +$353K | 0.03% | 548 |
|
2014
Q4 | $8.17M | Sell |
153,510
-5,314
| -3% | -$283K | 0.02% | 567 |
|
2014
Q3 | $7.11M | Buy |
158,824
+11,675
| +8% | +$523K | 0.02% | 595 |
|
2014
Q2 | $6.21M | Sell |
147,149
-6,321
| -4% | -$267K | 0.02% | 696 |
|
2014
Q1 | $6.76M | Sell |
153,470
-16,934
| -10% | -$746K | 0.02% | 670 |
|
2013
Q4 | $8.36M | Buy |
170,404
+910
| +0.5% | +$44.6K | 0.02% | 567 |
|
2013
Q3 | $6.98M | Buy |
169,494
+48,578
| +40% | +$2M | 0.02% | 653 |
|
2013
Q2 | $4.25M | Buy |
+120,916
| New | +$4.25M | 0.01% | 849 |
|